Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Diabetes Mellitus: HELP
Julio Rosenstock
Based on 90 articles published since 2007
||||
Expertise Level
The expertise of Julio Rosenstock ranks in the
  • Top 0.0022%
  • ... of 275,240 published authors worldwide on Diabetes Mellitus
  • ... from 2007 through 2018
  • ... based on contributions to 90 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Rosenstock, J   ·   Rosenstock, Julio
Work Locations
Details
Most likely:    University of Texas Southwestern   Contact    
2018
  • American Diabetes Association, Arlington, VA · Cedars-Sinai Medical Center, Los Angeles, CA. · McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. · Diabetes Trial Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, U.K. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. · Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL. · Duke University Medical Center, Durham, NC. · University of North Carolina School of Medicine, Chapel Hill, NC. · Yale School of Medicine and Yale New Haven Hospital, New Haven, CT. · Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Departments of Medicine and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · Oregon Health & Science University, Portland, OR. · Pubmed 29263194
2017
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA · University of North Carolina School of Medicine, Chapel Hill, NC. · Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland. · Dasman Diabetes Institute, Dasman, Kuwait. · Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia. · Center for Vascular Prevention, Danube University Krems, Krems, Austria. · Kinexum, Harper's Ferry, WV. · CNR Institute of Clinical Physiology, Pisa, Italy. · McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. · National Institutes of Health, Phoenix, AZ. · India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · VA Puget Sound Health Care System and University of Washington, Seattle, WA. · Pubmed 28108540
2016
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA. · University of North Carolina School of Medicine, Chapel Hill, NC. · Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; Dasman Diabetes Institute, Dasman, Kuwait; Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia; and Center for Vascular Prevention, Danube University Krems, Krems, Austria. · Kinexum, Harpers Ferry, WV. · CNR Institute of Clinical Physiology, Pisa, Italy. · McMaster University and Hamilton Health Sciences, Hamilton, Canada. · National Institutes of Health, Phoenix, AZ. · India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes and Endocrine Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · VA Puget Sound Health Care System and University of Washington, Seattle, WA. · Pubmed 27631469
2015
  • Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany · Dallas Diabetes and Endocrine Center at Medical City and University of Texas, Southwestern Medical Center, Dallas, TX, USA. · Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada University of Toronto, Toronto, ON, Canada. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · The Biostatistics Center, The George Washington University, Rockville, MD, USA. · Department of Biostatistics, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bruxelles, Belgium. · Boehringer Ingelheim, Bracknell, UK. · Boehringer Ingelheim, Asker, Norway. · Pubmed 25780262
2014
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA · University of North Carolina School of Medicine, Chapel Hill, NC. · Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy. · Newcastle University, Newcastle upon Tyne, U.K. · Icahn School of Medicine at Mt. Sinai, New York, NY. · Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes and Endocrine Center at Medical City and University of Texas Southwestern Medical Center, Dallas, TX. · Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, OR. · Pubmed 25147257
2016
  • From the Research Medical Center, Kansas City, MO (S.P.M.); School of Medicine, Swansea University, Swansea, United Kingdom (S.C.B.); Department of Medicine and Aging Science and Center of Excellence on Aging and Translational Medicine, G. d'Annunzio University, Chieti-Pescara, Italy (A.C.); CPClin Research Center/Hospital Israelita Albert Einstein, São Paulo (F.G.E.); Hospital Universitario Quirón Salud Madrid, Facultad de Ciencias de la Salud, Universidad Europea de Madrid, Madrid (E.J.); Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and the University of Manitoba, Winnipeg (V.W.) - both in Canada; University of Texas Southwestern Medical Center (I.L.) and Dallas Diabetes Research Center at Medical City (J.R.) - both in Dallas; University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany (J.S.); Physicians East, Greenville, NC (M.L.W.); and Novo Nordisk, Søborg (O.H., A.G.H., J.P.), and the Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup (T.V.) - both in Denmark. · Pubmed 27633186
2015
  • Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA, · Pubmed 26031671
Probable:    Miscellaneous institutions in Dallas      
2017
  • Diabetes Research Centre, University of Leicester, Leicester, United Kingdom. · Medical University of Graz, Graz, Austria. · Novo Nordisk A/S, Søborg, Denmark. · Thomas Jefferson University, Philadelphia, Pennsylvania. · Dallas Diabetes Research Center at Medical City, Dallas, Texas. · Pubmed 29049653
  • Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. · The George Institute for Global Health, University of Sydney, Sydney, Australia. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Pubmed 28830955
  • Department of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC. · Rockville Internal Medicine Group, Rockville, MD. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Novo Nordisk A/S, Bagsvaerd, Denmark. · Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands · Pubmed 28473337
  • Baylor University Medical Center, Dallas, TX · Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Janssen Research & Development, LLC, Spring House, PA. · Janssen Research & Development, LLC, Raritan, NJ. · Janssen Research & Development, Beerse, Belgium. · Pubmed 28289041
  • Department of Endocrinology, Academic Medical Center at the University of Amsterdam, Amsterdam, the Netherlands · Dallas Diabetes Research Center, Dallas, TX. · Pubmed 28108536
2016
  • Dallas Diabetes Research Center at Medical City, Dallas, TX · LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. · Grunberger Diabetes Institute, Bloomfield Hills, MI. · GWT-TUD GmbH, Dresden Technical University, Dresden, Germany. · San Raffaele Scientific Institute, Milan, Italy. · Groupe Hospitalier Mutualiste Les Portes du Sud, Vénissieux, France. · Sanofi R&D, Beijing, China. · Sanofi, Bridgewater, NJ. · Diabetes Division, Sanofi, Frankfurt, Germany. · Diabetes Division, Sanofi, Paris, France. · Diabetes Research Centre, University of Leicester, Leicester, U.K. · Pubmed 27527848
  • Centre Hospitalier Universitaire Poitiers and INSERM CIC 1402, Poitiers, France · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27493136
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA. · Department of Diabetology, Endocrinology and Nutrition, Hopital Bichat Claude Bernard, Paris, France. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 27484021
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · VU University Medical Center, Amsterdam, the Netherlands. · MedStar Health Research Institute, Hyattsville, MD. · Sanofi, Paris, France. · Sanofi, Bridgewater, NJ. · Tulane University Health Sciences Center, New Orleans, LA. · Pubmed 27284114
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Diablo Clinical Research, Walnut Creek, CA. · Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara, Guadalajara, Mexico. · Janssen Research & Development, LLC, Raritan, NJ. · Pubmed 26786577
  • University of North Carolina School of Medicine, Chapel Hill, NC. · University of Texas Health Science Center, San Antonio, TX. · Dallas Diabetes and Endocrine Center, Dallas, TX. · Elcelyx Therapeutics, San Diego, CA. · Elcelyx Therapeutics, San Diego, CA · Pubmed 26285584
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas. · Texas Diabetes and Endocrinology, Austin, Texas. · International Diabetes Center at Park Nicollet, Minneapolis, Minnesota. · Profil Institute for Clinical Research Inc., Chula Vista, California. · Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 26278063
  • Medstar Health Research Institute, Hyattsville, MD · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Rockwood Clinic, Spokane, WA. · Catalina Research Institute, Chino, CA. · Complejo Hospitalario Universitario de Ferrol, A Coruña University, A Coruña, Spain. · Instituto Jalisciense de Investigación en Diabetes y Obesidad S. C., Universidad de Guadalajara, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca," Guadalajara, Mexico. · Sanofi, Tokyo, Japan. · Biostatistics, BMD Consulting Inc., Somerset, NJ. · Diabetes Division, Sanofi, Frankfurt, Germany. · Diabetes Division, Sanofi, Paris, France. · International Diabetes Center, Park Nicollet Health Services, Minneapolis, MN. · Pubmed 27650977
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · University of Lorraine and the Department of Diabetology, Metabolic Diseases and Nutrition, Brabois Adult Hospital, Vandœuvre-lès-Nancy, France. · GWT-TUD, Study Centre Prof. Hanefeld, Dresden Technical University, Dresden, Germany. · Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy. · LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. · Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health and Hospital Virgen de la Victoria, Malaga, Spain. · Sanofi, Paris, France. · Sanofi, Warsaw, Poland. · Sanofi, Bridgewater, NJ. · Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield, Sheffield, U.K. · Pubmed 27222510
  • Valme University Hospital Medical School, Seville, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Medicine, University of Helsinki, Helsinki, Finland. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Ltd, Bracknell, UK. · Pubmed 26605991
2015
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · CPCLIN Clinical Research Center, São Paulo, Brazil. · V.P. Komissarenko Institute of Endocrinology and Metabolism of AMS of Ukraine, Kiev, Ukraine. · Regeneron Pharmaceuticals, Tarrytown, NY. · MannKind Corporation, Paramus, NJ. · Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO. · Pubmed 26253730
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26040302
  • Texas Diabetes & Endocrinology, Austin, TX, USA. · Gemeinschaftspraxis für Innere Medizin und Diabetologie, Hamburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 25974640
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Baylor Endocrine Center, Dallas, TX, USA. · Iowa Diabetes and Endocrinology Research Center, Des Moines, IA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 25931141
  • Dallas Diabetes and Endocrine Center, Dallas, TX · Bristol-Myers Squibb, Princeton, NJ. · AstraZeneca, Wilmington, DE. · Pubmed 25352655
  • Oregon Health and Science University, Portland, OR, USA. · Endocrine and Metabolic Consultants, Rockville, MD, USA. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · University Hospital, Tampere University, Tampere, Finland. · Servicio Diabetología y Nutrición, Hospital Privado de Córdoba S.A., Córdoba, Argentina. · Medical and Science, GLP-1 and Obesity, Novo Nordisk A/S, Søborg, Denmark. · Novo Nordisk Service Centre, India Pvt Ltd, Bangalore, India. · Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-Universität Bochum), Bochum, Germany. · Pubmed 26179619
  • Diabetes Research Institute, University of Miami, Miami, FL · Tulane University Health Sciences Center, New Orleans, LA. · Mesoblast Inc., New York, NY. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Pubmed 26153271
  • Lexicon Pharmaceuticals, Inc., The Woodlands, TX · Lexicon Pharmaceuticals, Inc., The Woodlands, TX. · Dallas Diabetes and Endocrine Center, Dallas, TX. · Atlanta Diabetes Associates, Atlanta, GA. · University of Colorado Denver/Barbara Davis Center for Childhood Diabetes, Aurora, CO. · University of North Carolina School of Medicine, Chapel Hill, NC. · Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. · Creighton Diabetes Center, Omaha, NE. · Pennington Biomedical Research Center, Baton Rouge, LA. · Pubmed 26049551
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, Berkshire, UK. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Drengsrudbekken 8, 1373 Asker, Oslo, Norway. · Pubmed 25990013
  • Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. Electronic address: · George Institute for Global Health, University of Sydney, New South Wales, Australia. · Washington University in St Louis, St Louis, MO. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. · University of Würzburg, Würzburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 25960304
  • Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Sanofi R&D, Chilly-Mazarin, France. · Profil, Neuss, Germany. · Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany. · Profil, Mainz, Germany. · Pubmed 25887358
  • Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Department of Medicine, Division of Nephrology, Helsinki University Central Hospital, Helsinki, Finland; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; and Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Diabetes and Endocrinology Centre, Heart of England National Health Service Foundation Trust, and University of Birmingham, Birmingham, U.K. · Department of Medicine IV, Universitäts-Klinikum Tübingen, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ky, Helsinki, Finland. · Boehringer Ingelheim Ltd., Bracknell, U.K. · Pubmed 25614693
  • Center for Metabolic Research, VA San Diego Healthcare System, San Diego, CA University of California, San Diego, La Jolla, CA · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Center for Metabolic Research, VA San Diego Healthcare System, San Diego, CA University of California, San Diego, La Jolla, CA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · Bristol-Myers Squibb, Princeton, NJ. · Pubmed 25271207
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA. · Lexicon Pharmaceuticals, Inc., The Woodlands, TX. · Pubmed 25216510
2014
  • Eastern Virginia Medical School, Norfolk, VA · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · MMS Holdings Inc., Canton, MI. · Daiichi Sankyo Pharma Development, Edison, NJ. · Daiichi Sankyo Development, Gerrards Cross, Buckinghamshire, U.K. · Pubmed 25231896
  • Florida Hospital Diabetes and Translational Research Institute, Sanford-Burnham Medical Research Institute, Orlando, FL, USA. Electronic address: · Diabeteszentrum Bad Lauterberg, Harz, Germany. · Birmingham Heartlands Hospital, Birmingham, UK. · Duke University, Durham, NC, USA. · University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA. · Ben-Gurion University of the Negev, Beer Sheva, Israel. · GlaxoSmithKline, Research Triangle Park, NC, USA. · GlaxoSmithKline, Stevenage, Hertfordshire, UK. · GlaxoSmithKline, Upper Merion, PA, USA. · Dallas Diabetes and Endocrine Center, Dallas, TX, USA. · Pubmed 24703047
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. Electronic address: · Centre for Clinical Studies, GWT-TUD GmbH, Dresden, Germany. · Bangalore Diabetes Centre, Bangalore, India. · Eulji General Hospital, Seoul, Republic of Korea. · Sanofi R&D, Chilly-Mazarin, France. · Sanofi R&D, Paris, France. · Sanofi, Bridgewater, NJ, USA. · Sanofi R&D, Frankfurt, Germany. · Medstar Health Research Institute and Georgetown University Medical School, Washington, DC, USA. · Pubmed 24650952
  • VA San Diego Healthcare System, San Diego, CA and University of California, San Diego, La Jolla, CA. Electronic address: · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Medpace Clinical Pharmacology Unit, Cincinnati, OH. · Intarcia Therapeutics Inc., Hayward, CA. · Pubmed 24631129
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Daiichi Sankyo Pharma Development, Edison, NJ, USA. · Pubmed 25054436
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24929430
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. Electronic address: · Tulane University Health Sciences Center, New Orleans, LA, USA. · Sanofi Deutschland GmbH, Frankfurt, Germany. · Sanofi, Paris, France. · Department of Statistics, University of Auckland, Auckland, New Zealand. · Oregon Health & Science University, Portland, OR, USA. · Pubmed 24856612
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Summit Research Group, Stow, Ohio, USA. · Daiichi Sankyo Pharma Development, Edison, NJ, USA. · Pubmed 24356792
  • University Hospital Sainte Marguerite, Marseille, France. Electronic address: · Outcomes Research, Novosys Health, Flemington, NJ, USA. · Diabetes-Metabolism Franchise, Sanofi-Aventis US, Bridgewater, NJ, USA. · Diabetes-Metabolism Franchise, Sanofi, Paris, France. · University of Verona Medical School and Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy. · Dr Negrin Hospital, Las Palmas University, Las Palmas, Spain. · Department of Diabetology, Endocrinology and Nutrition, Assistance Publique Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM, Research Unit 872, Paris, France; University Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 24246441
2013
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23449634
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23906374
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23802840
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23746555
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23531118
  • Dallas Diabetes and Endocrine Center at Medical City Dallas, Dallas, TX, USA. · Pubmed 23193209
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23139373
2012
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX 75230 , USA. · Pubmed 22913890
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX 75230, USA. · Pubmed 22913889
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA. · Pubmed 22492586
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 22446170
Probable:    Medical City Dallas Hospital      
2014
  • Dallas Diabetes and Endocrine Center, Medical City Dallas Hospital, Dallas, TX · Tulane University Health Sciences Center, New Orleans, LA. · Endocrine Division, Hospital de Clínicas de Porto Alegre and Universidade Federal do Sul, Porto Alegre, Brazil. · Medstar Health Research Institute, Hyattsville, MD. · Department of Medicine, Lund University, Lund, Sweden. · The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. · GlaxoSmithKline, Upper Merion, PA. · GlaxoSmithKline, Research Triangle Park, NC. · Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24898300
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 90 total) written by Julio Rosenstock about Diabetes Mellitus:

  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a 2018
  • Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. 2017
  • Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point? 2017
  • Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. 2017
  • Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial. 2017
  • DPP-4 Inhibitor-Related Pancreatitis: Rare but Real! 2017
  • Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201. 2017
  • Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. 2016
  • Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. 2016
  • Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes. 2016
Show List of Full Article Records
Google Searches

Learn more about Julio Rosenstock using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Southwestern
Miscellaneous institutions in Dallas
Medical City Dallas Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Southwestern
2018
  • American Diabetes Association, Arlington, VA · Cedars-Sinai Medical Center, Los Angeles, CA. · McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. · Diabetes Trial Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, U.K. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. · Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL. · Duke University Medical Center, Durham, NC. · University of North Carolina School of Medicine, Chapel Hill, NC. · Yale School of Medicine and Yale New Haven Hospital, New Haven, CT. · Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Departments of Medicine and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · Oregon Health & Science University, Portland, OR. · Pubmed 29263194
2017
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA · University of North Carolina School of Medicine, Chapel Hill, NC. · Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland. · Dasman Diabetes Institute, Dasman, Kuwait. · Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia. · Center for Vascular Prevention, Danube University Krems, Krems, Austria. · Kinexum, Harper's Ferry, WV. · CNR Institute of Clinical Physiology, Pisa, Italy. · McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. · National Institutes of Health, Phoenix, AZ. · India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes Research Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · VA Puget Sound Health Care System and University of Washington, Seattle, WA. · Pubmed 28108540
2016
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA. · University of North Carolina School of Medicine, Chapel Hill, NC. · Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; Dasman Diabetes Institute, Dasman, Kuwait; Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia; and Center for Vascular Prevention, Danube University Krems, Krems, Austria. · Kinexum, Harpers Ferry, WV. · CNR Institute of Clinical Physiology, Pisa, Italy. · McMaster University and Hamilton Health Sciences, Hamilton, Canada. · National Institutes of Health, Phoenix, AZ. · India Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes and Endocrine Center at Medical City and The University of Texas Southwestern Medical Center, Dallas, TX. · VA Puget Sound Health Care System and University of Washington, Seattle, WA. · Pubmed 27631469
2015
  • Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany · Dallas Diabetes and Endocrine Center at Medical City and University of Texas, Southwestern Medical Center, Dallas, TX, USA. · Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada University of Toronto, Toronto, ON, Canada. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · The Biostatistics Center, The George Washington University, Rockville, MD, USA. · Department of Biostatistics, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bruxelles, Belgium. · Boehringer Ingelheim, Bracknell, UK. · Boehringer Ingelheim, Asker, Norway. · Pubmed 25780262
2014
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA · University of North Carolina School of Medicine, Chapel Hill, NC. · Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy. · Newcastle University, Newcastle upon Tyne, U.K. · Icahn School of Medicine at Mt. Sinai, New York, NY. · Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany. · Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel. · Dallas Diabetes and Endocrine Center at Medical City and University of Texas Southwestern Medical Center, Dallas, TX. · Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, OR. · Pubmed 25147257
2016
  • From the Research Medical Center, Kansas City, MO (S.P.M.); School of Medicine, Swansea University, Swansea, United Kingdom (S.C.B.); Department of Medicine and Aging Science and Center of Excellence on Aging and Translational Medicine, G. d'Annunzio University, Chieti-Pescara, Italy (A.C.); CPClin Research Center/Hospital Israelita Albert Einstein, São Paulo (F.G.E.); Hospital Universitario Quirón Salud Madrid, Facultad de Ciencias de la Salud, Universidad Europea de Madrid, Madrid (E.J.); Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and the University of Manitoba, Winnipeg (V.W.) - both in Canada; University of Texas Southwestern Medical Center (I.L.) and Dallas Diabetes Research Center at Medical City (J.R.) - both in Dallas; University of Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany (J.S.); Physicians East, Greenville, NC (M.L.W.); and Novo Nordisk, Søborg (O.H., A.G.H., J.P.), and the Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup (T.V.) - both in Denmark. · Pubmed 27633186
2015
  • Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA, · Pubmed 26031671
Miscellaneous institutions in Dallas
2017
  • Diabetes Research Centre, University of Leicester, Leicester, United Kingdom. · Medical University of Graz, Graz, Austria. · Novo Nordisk A/S, Søborg, Denmark. · Thomas Jefferson University, Philadelphia, Pennsylvania. · Dallas Diabetes Research Center at Medical City, Dallas, Texas. · Pubmed 29049653
  • Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. · The George Institute for Global Health, University of Sydney, Sydney, Australia. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Pubmed 28830955
  • Department of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC. · Rockville Internal Medicine Group, Rockville, MD. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Novo Nordisk A/S, Bagsvaerd, Denmark. · Department of Endocrinology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands · Pubmed 28473337
  • Baylor University Medical Center, Dallas, TX · Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Janssen Research & Development, LLC, Spring House, PA. · Janssen Research & Development, LLC, Raritan, NJ. · Janssen Research & Development, Beerse, Belgium. · Pubmed 28289041
  • Department of Endocrinology, Academic Medical Center at the University of Amsterdam, Amsterdam, the Netherlands · Dallas Diabetes Research Center, Dallas, TX. · Pubmed 28108536
2016
  • Dallas Diabetes Research Center at Medical City, Dallas, TX · LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. · Grunberger Diabetes Institute, Bloomfield Hills, MI. · GWT-TUD GmbH, Dresden Technical University, Dresden, Germany. · San Raffaele Scientific Institute, Milan, Italy. · Groupe Hospitalier Mutualiste Les Portes du Sud, Vénissieux, France. · Sanofi R&D, Beijing, China. · Sanofi, Bridgewater, NJ. · Diabetes Division, Sanofi, Frankfurt, Germany. · Diabetes Division, Sanofi, Paris, France. · Diabetes Research Centre, University of Leicester, Leicester, U.K. · Pubmed 27527848
  • Centre Hospitalier Universitaire Poitiers and INSERM CIC 1402, Poitiers, France · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27493136
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA. · Department of Diabetology, Endocrinology and Nutrition, Hopital Bichat Claude Bernard, Paris, France. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 27484021
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · VU University Medical Center, Amsterdam, the Netherlands. · MedStar Health Research Institute, Hyattsville, MD. · Sanofi, Paris, France. · Sanofi, Bridgewater, NJ. · Tulane University Health Sciences Center, New Orleans, LA. · Pubmed 27284114
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Diablo Clinical Research, Walnut Creek, CA. · Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara, Guadalajara, Mexico. · Janssen Research & Development, LLC, Raritan, NJ. · Pubmed 26786577
  • University of North Carolina School of Medicine, Chapel Hill, NC. · University of Texas Health Science Center, San Antonio, TX. · Dallas Diabetes and Endocrine Center, Dallas, TX. · Elcelyx Therapeutics, San Diego, CA. · Elcelyx Therapeutics, San Diego, CA · Pubmed 26285584
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas. · Texas Diabetes and Endocrinology, Austin, Texas. · International Diabetes Center at Park Nicollet, Minneapolis, Minnesota. · Profil Institute for Clinical Research Inc., Chula Vista, California. · Lilly Diabetes, Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 26278063
  • Medstar Health Research Institute, Hyattsville, MD · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Rockwood Clinic, Spokane, WA. · Catalina Research Institute, Chino, CA. · Complejo Hospitalario Universitario de Ferrol, A Coruña University, A Coruña, Spain. · Instituto Jalisciense de Investigación en Diabetes y Obesidad S. C., Universidad de Guadalajara, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca," Guadalajara, Mexico. · Sanofi, Tokyo, Japan. · Biostatistics, BMD Consulting Inc., Somerset, NJ. · Diabetes Division, Sanofi, Frankfurt, Germany. · Diabetes Division, Sanofi, Paris, France. · International Diabetes Center, Park Nicollet Health Services, Minneapolis, MN. · Pubmed 27650977
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · University of Lorraine and the Department of Diabetology, Metabolic Diseases and Nutrition, Brabois Adult Hospital, Vandœuvre-lès-Nancy, France. · GWT-TUD, Study Centre Prof. Hanefeld, Dresden Technical University, Dresden, Germany. · Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy. · LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. · Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health and Hospital Virgen de la Victoria, Malaga, Spain. · Sanofi, Paris, France. · Sanofi, Warsaw, Poland. · Sanofi, Bridgewater, NJ. · Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield, Sheffield, U.K. · Pubmed 27222510
  • Valme University Hospital Medical School, Seville, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Medicine, University of Helsinki, Helsinki, Finland. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Ltd, Bracknell, UK. · Pubmed 26605991
2015
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · CPCLIN Clinical Research Center, São Paulo, Brazil. · V.P. Komissarenko Institute of Endocrinology and Metabolism of AMS of Ukraine, Kiev, Ukraine. · Regeneron Pharmaceuticals, Tarrytown, NY. · MannKind Corporation, Paramus, NJ. · Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO. · Pubmed 26253730
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26040302
  • Texas Diabetes & Endocrinology, Austin, TX, USA. · Gemeinschaftspraxis für Innere Medizin und Diabetologie, Hamburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 25974640
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Baylor Endocrine Center, Dallas, TX, USA. · Iowa Diabetes and Endocrinology Research Center, Des Moines, IA, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 25931141
  • Dallas Diabetes and Endocrine Center, Dallas, TX · Bristol-Myers Squibb, Princeton, NJ. · AstraZeneca, Wilmington, DE. · Pubmed 25352655
  • Oregon Health and Science University, Portland, OR, USA. · Endocrine and Metabolic Consultants, Rockville, MD, USA. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · University Hospital, Tampere University, Tampere, Finland. · Servicio Diabetología y Nutrición, Hospital Privado de Córdoba S.A., Córdoba, Argentina. · Medical and Science, GLP-1 and Obesity, Novo Nordisk A/S, Søborg, Denmark. · Novo Nordisk Service Centre, India Pvt Ltd, Bangalore, India. · Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-Universität Bochum), Bochum, Germany. · Pubmed 26179619
  • Diabetes Research Institute, University of Miami, Miami, FL · Tulane University Health Sciences Center, New Orleans, LA. · Mesoblast Inc., New York, NY. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Pubmed 26153271
  • Lexicon Pharmaceuticals, Inc., The Woodlands, TX · Lexicon Pharmaceuticals, Inc., The Woodlands, TX. · Dallas Diabetes and Endocrine Center, Dallas, TX. · Atlanta Diabetes Associates, Atlanta, GA. · University of Colorado Denver/Barbara Davis Center for Childhood Diabetes, Aurora, CO. · University of North Carolina School of Medicine, Chapel Hill, NC. · Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. · Creighton Diabetes Center, Omaha, NE. · Pennington Biomedical Research Center, Baton Rouge, LA. · Pubmed 26049551
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, Berkshire, UK. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Drengsrudbekken 8, 1373 Asker, Oslo, Norway. · Pubmed 25990013
  • Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. Electronic address: · George Institute for Global Health, University of Sydney, New South Wales, Australia. · Washington University in St Louis, St Louis, MO. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. · University of Würzburg, Würzburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 25960304
  • Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Sanofi R&D, Chilly-Mazarin, France. · Profil, Neuss, Germany. · Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany. · Profil, Mainz, Germany. · Pubmed 25887358
  • Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Department of Medicine, Division of Nephrology, Helsinki University Central Hospital, Helsinki, Finland; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; and Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Diabetes and Endocrinology Centre, Heart of England National Health Service Foundation Trust, and University of Birmingham, Birmingham, U.K. · Department of Medicine IV, Universitäts-Klinikum Tübingen, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ky, Helsinki, Finland. · Boehringer Ingelheim Ltd., Bracknell, U.K. · Pubmed 25614693
  • Center for Metabolic Research, VA San Diego Healthcare System, San Diego, CA University of California, San Diego, La Jolla, CA · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Center for Metabolic Research, VA San Diego Healthcare System, San Diego, CA University of California, San Diego, La Jolla, CA. · Bristol-Myers Squibb, Braine-l'Alleud, Belgium. · Bristol-Myers Squibb, Princeton, NJ. · Pubmed 25271207
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA. · Lexicon Pharmaceuticals, Inc., The Woodlands, TX. · Pubmed 25216510
2014
  • Eastern Virginia Medical School, Norfolk, VA · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · MMS Holdings Inc., Canton, MI. · Daiichi Sankyo Pharma Development, Edison, NJ. · Daiichi Sankyo Development, Gerrards Cross, Buckinghamshire, U.K. · Pubmed 25231896
  • Florida Hospital Diabetes and Translational Research Institute, Sanford-Burnham Medical Research Institute, Orlando, FL, USA. Electronic address: · Diabeteszentrum Bad Lauterberg, Harz, Germany. · Birmingham Heartlands Hospital, Birmingham, UK. · Duke University, Durham, NC, USA. · University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA. · Ben-Gurion University of the Negev, Beer Sheva, Israel. · GlaxoSmithKline, Research Triangle Park, NC, USA. · GlaxoSmithKline, Stevenage, Hertfordshire, UK. · GlaxoSmithKline, Upper Merion, PA, USA. · Dallas Diabetes and Endocrine Center, Dallas, TX, USA. · Pubmed 24703047
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. Electronic address: · Centre for Clinical Studies, GWT-TUD GmbH, Dresden, Germany. · Bangalore Diabetes Centre, Bangalore, India. · Eulji General Hospital, Seoul, Republic of Korea. · Sanofi R&D, Chilly-Mazarin, France. · Sanofi R&D, Paris, France. · Sanofi, Bridgewater, NJ, USA. · Sanofi R&D, Frankfurt, Germany. · Medstar Health Research Institute and Georgetown University Medical School, Washington, DC, USA. · Pubmed 24650952
  • VA San Diego Healthcare System, San Diego, CA and University of California, San Diego, La Jolla, CA. Electronic address: · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Medpace Clinical Pharmacology Unit, Cincinnati, OH. · Intarcia Therapeutics Inc., Hayward, CA. · Pubmed 24631129
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Daiichi Sankyo Pharma Development, Edison, NJ, USA. · Pubmed 25054436
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24929430
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. Electronic address: · Tulane University Health Sciences Center, New Orleans, LA, USA. · Sanofi Deutschland GmbH, Frankfurt, Germany. · Sanofi, Paris, France. · Department of Statistics, University of Auckland, Auckland, New Zealand. · Oregon Health & Science University, Portland, OR, USA. · Pubmed 24856612
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Summit Research Group, Stow, Ohio, USA. · Daiichi Sankyo Pharma Development, Edison, NJ, USA. · Pubmed 24356792
  • University Hospital Sainte Marguerite, Marseille, France. Electronic address: · Outcomes Research, Novosys Health, Flemington, NJ, USA. · Diabetes-Metabolism Franchise, Sanofi-Aventis US, Bridgewater, NJ, USA. · Diabetes-Metabolism Franchise, Sanofi, Paris, France. · University of Verona Medical School and Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy. · Dr Negrin Hospital, Las Palmas University, Las Palmas, Spain. · Department of Diabetology, Endocrinology and Nutrition, Assistance Publique Hôpitaux de Paris, Bichat Hospital, Paris, France; INSERM, Research Unit 872, Paris, France; University Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 24246441
2013
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23449634
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23906374
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23802840
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23746555
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23531118
  • Dallas Diabetes and Endocrine Center at Medical City Dallas, Dallas, TX, USA. · Pubmed 23193209
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 23139373
2012
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX 75230 , USA. · Pubmed 22913890
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX 75230, USA. · Pubmed 22913889
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA. · Pubmed 22492586
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Pubmed 22446170
Medical City Dallas Hospital
2014
  • Dallas Diabetes and Endocrine Center, Medical City Dallas Hospital, Dallas, TX · Tulane University Health Sciences Center, New Orleans, LA. · Endocrine Division, Hospital de Clínicas de Porto Alegre and Universidade Federal do Sul, Porto Alegre, Brazil. · Medstar Health Research Institute, Hyattsville, MD. · Department of Medicine, Lund University, Lund, Sweden. · The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. · GlaxoSmithKline, Upper Merion, PA. · GlaxoSmithKline, Research Triangle Park, NC. · Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24898300
Unspecified
2013
2014
2013
Eli Lilly Corporation
2012
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas; 2Eli Lilly and Company,Indianapolis, Indiana, USA. · Pubmed 22432107
22 Other Locations Show
Yearly article counts 16132017231000000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.